Delivery Order SPE2DB20D7061-SPE2DB24FSPW5

Award Date 9/19/24
Potential Completion Date 9/20/24
Potential Value $6.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,561.45, is for the procurement of DIGIFAB 40 MG VIALS, a medical product. The contract is a Firm Fixed Price (FFP) Delivery Order with a period of performance through March 2025. This contract is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $49,743.59, is a Delivery Order for "DIGIFAB 40 MG VIALS" and has a firm fixed price. The contract has an ultimate completion date of April 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of DIGIFAB 40 MG VIALS medical supplies. The award, with a ceiling value of $45,245.21, was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $58,594.40, is a Firm Fixed Price Delivery Order for DIGIFAB 40 MG VIALS. The contract has an ultimate completion date of January 3, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award with ID SPE2DB22D1106|SPE2DB24FEFH8 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of DIGIFAB 40 MG VIALS, a pharmaceutical product, with a firm fixed price and a ceiling value of $31,819.61. The contract has an ultimate completion date of March 19, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,708.88 firm-fixed-price delivery order is for 4560539206 DIGIFAB 40 MG VIALS, with an ultimate completion date of April 11, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,044.15 firm fixed-price delivery order is for the supply of DIGIFAB 40 MG VIALS, a medical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $68,837.73, is for the delivery of DIGIFAB 40 MG VIALS, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance ending on February 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $14,737.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, awarded under the DLA's Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,635.27, is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract is for the supply of DIGIFAB 40 MG VIALS medical product to support military healthcare...
  • SPE2DB20D7061
    Indefinite Delivery Contract
  • SPE2DB20D7061-SPE2DB24FSPW5
    Delivery Order

This is a delivery order contract award to AmerisourceBergen Drug Corp for the delivery of DIGIFAB 40 MG VIALS. The contract has a ceiling value of $6,217.46 and is a firm fixed price contract awarded by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of September 20, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation.

Generated 12/19/24, 9:02 AM